Ketamine vs. Spravato: Which Is Better for Depression?

Key Takeaways: Spravato is FDA-approved for treatment-resistant depression, while generic ketamine is used off-label, meaning Spravato has undergone extensive clinical trials and regulatory review specifically for depression. Insurance is far more likely to cover Spravato, whereas ketamine infusions are often paid fully out of pocket, making Spravato more financially accessible for many patients. Spravato is […]